Hospitalizations with blood transfusions and transfusion-related adverse events in US acute care hospitals, 2016-2020. [PDF]
Kazakova SV +5 more
europepmc +1 more source
Overview of blood transfusion appropriateness with one-day point prevalence: Right decision? Right product? Right amount? [PDF]
Turhan AB +4 more
europepmc +1 more source
Viral Safety of Blood Products: Beyond HBV, HCV, and HIV. [PDF]
Juhl D.
europepmc +1 more source
Knowledge assessment of Tunisian junior doctors in transfusion medicine. [PDF]
Ghachem I +4 more
europepmc +1 more source
Artificial intelligence in the identification and prediction of adverse transfusion reactions(ATRs) and implications for clinical management: a systematic review of models and applications. [PDF]
ShojaeiBaghini M +2 more
europepmc +1 more source
Potential Health Consequences of Regular Blood Donation: Current Evidence and Remaining Uncertainties. [PDF]
Berli S +3 more
europepmc +1 more source
AI Applications in Transfusion Medicine: Opportunities, Challenges, and Future Directions.
Barzilai M, Cohen O.
europepmc +1 more source
Related searches:
Transfusion and Hemovigilance in Pediatrics
Pediatric Clinics of North America, 2013Hemovigilance is an essential part of the transfusion process and is defined as surveillance procedures covering the whole transfusion chain, from collection of blood and its components, intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products and to prevent their ...
Paula Bolton-Maggs
exaly +3 more sources
Pediatric Hemovigilance and Adverse Transfusion Reactions
Clinics in Laboratory Medicine, 2021Some types of transfusion reactions occur more frequently in the pediatric than the adult population. Allergic reactions are the most common, followed by nonhemolytic transfusion reactions; male children seem most susceptible to such reactions. Platelets are often implicated and pulmonary reactions are understudied in children.
Jeanne E Hendrickson, Nataliya Sostin
exaly +3 more sources

